Keliomics, Inc.
Biotechnology company · Portland, Oregon, United States
Keliomics, Inc. is a biotechnology company headquartered in Portland, Oregon, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $398,895 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $2.3 million sold in a notice filed in 2023.
Keliomics at a glance
What does Keliomics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $398,895 in total (2024). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.3 million sold (2023).
Frequently asked questions about Keliomics
Where is Keliomics headquartered?
Keliomics, Inc. is headquartered in Portland, Oregon, United States.
What does Keliomics do?
Keliomics, Inc. is a biotechnology company.
Similar companies
- Pacific Diabetes Technologies, Inc.Portland, Oregon, United States
- Nobilis Therapeutics IncPortland, Oregon, United States
- AMES Technology, Inc.Portland, Oregon, United States
- PDX Pharmaceuticals, Inc.Portland, Oregon, United States
- Aronora IncPortland, Oregon, United States
- Boulder Care Provider Group, P.APortland, Oregon, United States
- CytoImage Inc.Portland, Oregon, United States
- Sedia Biosciences CorpPortland, Oregon, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences